stanford school of medicine logotitle logo
advanced

 

 

Cardiology

 

Endocrinology

 

Gastroenterology

 

General Inpatient Medicine

 

Hematology

 

Infectious Disease

 

Nephrology

 

Neurology

 

Oncology

 

Outpatient & Preventative Medicine

 

Palliative Care

 

Psychiatry

 

Pulmonary/Critical Care

 

Rheumatology

Hairy Cell Leukemia

 

Overview

  • Rare, chronic B cell lymphoproliferative disorder
    • represents 2% of leukemias
    • avg age is 52 yrs
    • male> female with 4:1 ratio
    • caucasians 4x more likely to develop than others
  • assembles cytokines like TNF, which may cause pancytopenia by suppressing BM
  • At presentation, 25% with abdominal pain/splenomegaly, 25% with fatigues/weakness, 25% with bleeding, 25% asymptomatic
  • Indications for treatment include cytopenias, splenomegaly, constitutional symptoms, and treatment is often not initiated immediately; 10% never need treatment. Purine analogs are used as monotherapy initially. Either cladribine or pentostatin gives the median first-time patient a ten-year remission

 

Pathology

  • "hairy" projections are from villous cytoplasm and are seen on light and electron microscopy.
  • Bone marrow may be difficult to aspirate as it may be "dry" due to fibrosis in which case repeat core biopsies should be attempted. The biopsy shows a pattern of infiltration by the malignant cells and fibrosis


 

(Ellen Eaton MD, 7/23/10)